Search Options Stock News and Analysis from Schaeffer's

Options Traders Load Up On VKTX Calls Ahead of Earnings

https://www.schaeffersresearch.com/content/options/2019/07/31/options-traders-load-up-on-vktx-calls-ahead-of-earnings

7/31/2019 2:06 PM

The shares of Viking Therapeutics Inc (NASDAQ:VKTX) are up 3.3% to trade at $7.93 today, as the biotech concern prepares for its second-quarter earnings report, set for after the close tomorrow, Aug. ...

Pharma Stock Gaps Higher After NASH Drug Results

https://www.schaeffersresearch.com/content/news/2019/04/11/pharma-stock-gaps-higher-after-nash-drug-results

4/11/2019 9:50 AM

The shares of Viking Therapeutics Inc (NASDAQ:VKTX) are up 7.5% to trade at $10.89 this morning after the pharma company's non-alcoholic fatty liver disease (NASH) drug met the main goals for its mid-...

3 Pharma Stocks Expected to Double

https://www.schaeffersresearch.com/content/news/2019/03/29/3-pharma-stocks-expected-to-double

3/29/2019 10:40 AM

Analysts this morning waxed optimistic on biotech stocks Xenon Pharmaceuticals Inc (NASDAQ:XENE), TG Therapeutics Inc (NASDAQ:TGTX), and Viking Therapeutics Inc (NASDAQ:VKTX). In fact, the brokerag...

Options Volume Hot On Newly Upgraded Drug Stock

https://www.schaeffersresearch.com/content/options/2018/11/19/options-volume-hot-on-newly-upgraded-drug-stock

11/19/2018 2:04 PM

The shares of Viking Therapeutics Inc (NASDAQ:VKTX) are up 1.8% to trade at $11.86, getting a boost from Raymond James, who upgraded the biotech name to "strong buy" from "outperform. The analyst in ...

VKTX, EYEG Stocks Rally on Drug Updates

https://www.schaeffersresearch.com/content/news/2018/11/13/vktx-eyeg-stocks-rally-on-drug-updates

11/13/2018 9:10 AM

Viking Therapeutics Inc (NASDAQ:VKTX) is set to jump 18.5% at the open thanks to news the company's non-alcoholic fatty liver disease treatment met its main and secondary goals in a mid-stage study. ...

PEOPLE ALSO SEARCH FOR